Peter-Martin Bruch
Hat mitgewirkt an:
-
Die systematische Integration von genetischen Faktoren, Signalen des Mikromilieus und Medikamentenvulnerabilitäten in lympho-proliferativen primären Patientenzellen
-
Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients
-
Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL
-
Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entities